Dray Gentry, a clinical physicist on ORAU’s radiation epidemiology team, is the primary investigator for an ORAU-Directed Research and Development Grant project that aims to determine the feasibility of using artificial intelligence to speed up the process of identifying chromosomal abnormalities in the Radiation Emergency Assistance Center/Training Site Cytogenetic Biodosimetry Laboratory, which is part of the Oak Ridge Institute for Science and Education that ORAU manages for the U.S. Department of Energy. The second is to help determine the total dose cancer patients are exposed to during treatment. In this episode of Further Together, Gentry talks to hosts Michael Holtz and Amber Davis about his research, why it’s important and what he hopes to accomplish in the next phase of his project.